DEA Publishes Bulk Manufacturer Application Notice for Siemens Healthcare Diagnostics Inc.
April 27, 2025
April 27, 2025
WASHINGTON, April 27 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has issued a notice regarding an application from Siemens Healthcare Diagnostics Inc. to become a registered bulk manufacturer of a controlled substance. The notice, published in the Federal Register on April 28, 2025, details that Siemens Healthcare Diagnostics Inc., with a facility located in Newark, Delaware 19702-2461, submitted its application on January 15, 2025.
The company i . . .
The company i . . .